| The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype F De Bacco, E Casanova, E Medico, S Pellegatta, F Orzan, R Albano, ... Cancer research 72 (17), 4537-4550, 2012 | 164 | 2012 |
| B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres D Nehama, N Di Ianni, S Musio, H Du, M Patané, B Pollo, G Finocchiaro, ... EBioMedicine 47, 33-43, 2019 | 126 | 2019 |
| Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma S Pellegatta, L Valletta, C Corbetta, M Patanè, I Zucca, F Riccardi Sirtori, ... Acta neuropathologica communications 3, 1-12, 2015 | 126 | 2015 |
| Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ... Science translational medicine 10 (430), eaao2731, 2018 | 120 | 2018 |
| Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of … L Calo, C Cinque, M Patane, D Schillaci, G Battaglia, D Melchiorri, ... Journal of neurochemistry 98 (1), 1-10, 2006 | 70 | 2006 |
| Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons L Calo, V Bruno, P Spinsanti, G Molinari, V Korkhov, Z Esposito, M Patanè, ... Journal of Neuroscience 25 (9), 2245-2254, 2005 | 40 | 2005 |
| First ex vivo validation of a radioguided surgery technique with β-radiation. ES Camillocci, M Schiariti, V Bocci, A Carollo, G Chiodi, M Colandrea, ... Physica Medica 32 (9), 1139-1144, 2016 | 36 | 2016 |
| High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient E Anghileri, N Di Ianni, R Paterra, T Langella, J Zhao, M Eoli, M Patanè, ... Cancer Immunology, Immunotherapy 70, 831-842, 2021 | 27 | 2021 |
| Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma C Corbetta, N Di Ianni, MG Bruzzone, M Patanè, B Pollo, G Cantini, ... International journal of cancer 144 (10), 2539-2554, 2019 | 27 | 2019 |
| ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma F De Bacco, F Orzan, J Erriquez, E Casanova, L Barault, R Albano, ... Cell Reports 36 (4), 2021 | 23 | 2021 |
| Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres M Patanè, P Porrati, E Bottega, S Morosini, G Cantini, V Girgenti, A Rizzo, ... Molecular Cancer 12, 1-12, 2013 | 15 | 2013 |
| Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness C Richichi, D Osti, M Del Bene, L Fornasari, M Patanè, B Pollo, F DiMeco, ... Oncotarget 7 (44), 71491, 2016 | 14 | 2016 |
| The β-radio-guided surgery: method to estimate the minimum injectable activity from ex-vivo test A Russomando, M Schiariti, V Bocci, M Colandrea, F Collamati, ... Physica Medica 58, 114-120, 2019 | 13 | 2019 |
| Long and very-long-chain ceramides correlate with a more aggressive behavior in skull base chordoma patients E La Corte, M Dei Cas, A Raggi, M Patanè, M Broggi, S Schiavolin, ... International Journal of Molecular Sciences 20 (18), 4480, 2019 | 11 | 2019 |
| Mutations targeting the coagulation pathway are enriched in brain metastases C Richichi, L Fornasari, GEM Melloni, P Brescia, M Patanè, M Del Bene, ... Scientific Reports 7 (1), 6573, 2017 | 10 | 2017 |
| Deciphering the labyrinthine system of the immune microenvironment in recurrent glioblastoma: recent original advances and lessons from clinical immunotherapeutic approaches E Anghileri, M Patanè, N Di Ianni, I Sambruni, M Maffezzini, M Milani, ... Cancers 13 (24), 6156, 2021 | 9 | 2021 |
| The search for molecular markers in a gene-orphan case study of a pediatric spinal cord pilocytic astrocytoma C Martinelli, F Gabriele, F Manai, R Ciccone, F Novara, E Sauta, ... Cancer Genomics & Proteomics 17 (2), 117-130, 2020 | 6 | 2020 |
| mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma V Conti, M Cominelli, V Pieri, AL Gallotti, I Pagano, M Zanella, ... JCI insight 6 (23), 2021 | 5 | 2021 |
| Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series E Anghileri, C Schettino, B Pollo, M Farinotti, A Silvani, R Paterra, ... Neurological Sciences 41, 2111-2120, 2020 | 5 | 2020 |
| Constitutive and TNF-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ... Sci. Transl. Med 10, 2018 | 4 | 2018 |
Chiara CalatozzoloFondazione IRCCS Istituto Neurologico “C. Besta”在 istituto-besta.it 的电子邮件经过验证
